Where Global Innovation
and Capital Meet
Sectors Art of CVCConsumerEnergyFinancialHealthIndustrialITMediaServicesStartupsTelecomsTransportUniversity

Page 430

Baidu helps Sherlock catch $31m

Baidu Ventures was among the participants in diagnostics technology developer Sherlock Biosciences' series A round, which has closed at $31m.

Apr 25, 2019

Explorer Surgical makes $5m intervention

Co-founded by a former UChicago research director, surgery workflow software provider Explorer Surgical has increased its total funding to $9m.

Apr 25, 2019

Sherlock catches $31m with Baidu’s help

Baidu Ventures has helped close a $31m series A round for Harvard-founded Sherlock Biosciences just over a month after the spinout launched with an initial $17.5m tranche.

Apr 25, 2019

Nocion plays nice to raise $27m

Nocion Therapeutics has raised $27m in a Partners Innovation Fund-backed series A round to develop drugs for pain and inflammation.

Apr 25, 2019

Satsuma snatches $62m in series B round

Shin Nippon Biomedical Laboratories was among the investors in its spinoff, which is working on treatments for acute migraine.

Apr 25, 2019

Nocion finds series A relief

Based on Harvard and Boston Children’s Hospital research, Nocion Therapeutics has raised $27m to develop drugs for pain and inflammation.

Apr 25, 2019

Satsuma squeezes $62m out of series B

Osage University Partners has participated in a $62m series B round for Satsuma Pharmaceuticals, which also featured Shin Nippon Biomedical Laboratories.

Apr 25, 2019

UT Health San Antonio to inaugurate TechNovum

The first cohort of TechNovum will feature five-to-eight inventors from the institute whose concepts have been sanctioned by its tech transfer office’s 12-week validation process.

Apr 24, 2019

Velocity fires up equity investments

Four businesses have collected $37,000 in equity funding each from a micro-VC fund established by University of Waterloo’s Velocity unit in support of the Velocity Fund Finals competition.

Apr 24, 2019

Guardant Health buys Bellwether Bio

University of Washington cancer diagnostics spinout Bellwether Bio has been acquired by Guardant Health, which plans to integrate the former's expertise to advance its own pipeline.

Apr 24, 2019
© 2026 Mawsonia Ltd. All rights reserved.
test reg

Login

Not yet subscribed?

See your subscription offers here